| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $22 | 1 | 100 |
| LONGNECKER BRENT M | director | 0 | $0 | 1 | $22 | $-22 |
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of …
Over the last 12 months, insiders at Genprex, Inc. have bought $0 and sold $22 worth of Genprex, Inc. stock.
On average, over the past 5 years, insiders at Genprex, Inc. have bought $41,523 and sold $22 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $21,478 was made by VACZY CATHERINE M (EVP GC Chief Strategy Officer) on 2023‑04‑21.
| 2026-04-14 | Sale | LONGNECKER BRENT M | director | 18 0.001% | $1.23 | $22 | -71.86% | |
| 2023-04-21 | VACZY CATHERINE M | EVP GC Chief Strategy Officer | 20,000 0.0426% | $1.07 | $21,478 | -70.00% | ||
| 2023-04-21 | Varner John Rodney | Chairman, President and CEO | 19,000 0.0398% | $1.05 | $20,045 | -70.00% | ||
| 2021-04-05 | LONGNECKER BRENT M | director | 15,000 0.0313% | $4.15 | $62,250 | -37.14% | ||
| 2019-09-05 | Varner John Rodney | Chief Executive Officer | 1,800 0.0116% | $0.89 | $1,595 | +168.97% | ||
| 2018-07-30 | Pham Julien L | President & COO | 500 0.0038% | $3.40 | $1,700 | -44.44% | ||
| 2018-03-29 | ROTH JACK A | 10 percent owner | 40,000 0.3625% | $5.00 | $200,000 | -44.68% | ||
| 2018-03-29 | Varner John Rodney | Chief Executive Officer | 10,000 0.0906% | $5.00 | $50,000 | -44.68% | ||
| 2018-03-29 | Nance Christy M. | 10 percent owner | 50,000 0.4531% | $5.00 | $250,000 | -44.68% |
| Increased Positions | 13 | +52% | 6,494 | +22.01% |
| Decreased Positions | 10 | -40% | 28,848 | -97.76% |
| New Positions | 10 | New | 3,266 | New |
| Sold Out Positions | 6 | Sold Out | 23,194 | Sold Out |
| Total Postitions | 28 | +12% | 7,155 | -75.75% |
| Vanguard Group Inc | $16.00 | 0.43% | 8,667 | +8,361 | +2,732.35% | 2025-09-30 |
| Susquehanna International Group, Llp | $12.00 | 0.34% | 6,801 | +713 | +11.71% | 2025-09-30 |
| Jane Street Group, Llc | $7.00 | 0.21% | 4,104 | +4,104 | New | 2025-09-30 |
| Geode Capital Management, Llc | $6.00 | 0.16% | 3,281 | +1,777 | +118.15% | 2025-09-30 |
| Ubs Group Ag | $6.00 | 0.16% | 3,244 | +619 | +23.58% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $4.00 | 0.12% | 2,421 | +2,373 | +4,943.75% | 2025-09-30 |
| Hub Investment Partners, Llc | $1.00 | 0.02% | 340 | +30 | +9.68% | 2025-09-30 |
| Blackrock, Inc. | $0 | 0.01% | 188 | -2 | -1.05% | 2025-09-30 |
| Osaic Holdings, Inc. | $0 | 0.01% | 172 | +170 | +8,500% | 2025-09-30 |
| Citigroup Inc | $0 | 0.01% | 122 | -130 | -51.59% | 2025-09-30 |